OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE 5 MAY 2025 AT 13.00 A.M. EET, INTERIM REPORT Q1 CORRECTION: Oma Savings Bank Plc’s Interim Report 1.1.-31.3.2025: High costs and declining market interest rates weighed on the result, work to strengthen OmaSp continues This release corrects the January-March interim report published today at 9.45 a.m. EET. The CEO’s review contained an incorrect figure regarding the total investments in the Noste project. The corrected sentence reads: Total investments in the Nos ...

Q1 2025 key highlights Financial performance for the first quarter was expected to be moderate, but macroeconomic and geopolitical uncertainty increased, which impacted NNIT. The uncertainty has influenced customer behavior, especially in the three regions focusing on IT Life Science solutions, where several projects have been postponed, most predominantly in Region Europe. Group revenue amounted to DKK 464.1m, entailing flat revenue growth compared with last year.Despite improving utilization and capacity ...

The first quarter financial performance was expected to be moderate, but the increased macroeconomic and geopolitical uncertainty has impacted NNIT to a larger extent than expected. Based on the realized results and the continued uncertainty, NNIT adjusts the 2025 financial outlook. Given the current uncertainty, organic revenue growth is expected to be 0% to 5% (previously 7% to 10%), which is due to postponement of projects and the sales pipeline materializing at a slower pace than planned as customers ar ...

Information on share capital and voting rights April 2025 Statement made in accordance with article L. 233-8 II of the French commercial Code and articles 221-1 2 ° f) and 223-16 of the AMF Regulations. May 5th, 2025 Statement made by: Nexans S.A.Registered office : 4 Allée de l’Arche - 92400 CourbevoieRCS Nanterre 393 525 852Regulated market of Euronext Paris (Compartment A) DateTotal number of sharesTotal number of voting rightsTheorical (1)Exercisable (2)April 30th, 202543,753,38043,753,380<td style="wi ...

Core Points - Sydbank has initiated a share buyback programme amounting to DKK 1,350 million, which started on 3 March 2025 and is set to conclude by 31 January 2026 [1][2] - The purpose of the share buyback is to reduce the share capital of Sydbank, adhering to the Safe Harbour rules under EU regulations [2] - As of week 18, a total of 69,000 shares were repurchased, with a gross value of DKK 28,868,640, bringing the total shares bought back to 696,000 and a total gross value of DKK 289,031,550 [2][3] Transaction Details - The share buyback transactions for week 18 included: - 14,000 shares on 28 April 2025 at a VWAP of DKK 412.31 - 15,000 shares on 29 April 2025 at a VWAP of DKK 414.63 - 15,000 shares on 30 April 2025 at a VWAP of DKK 417.09 - 13,000 shares on 01 May 2025 at a VWAP of DKK 421.22 - 12,000 shares on 02 May 2025 at a VWAP of DKK 428.72 [2] - Following these transactions, Sydbank now holds a total of 4,080,435 own shares, representing 7.47% of the bank's share capital [3]

Core Points - Pharma Equity Group A/S held its Annual General Meeting on April 16, 2025, where various proposals were discussed and adopted [1][6] Group 1: Board of Directors' Report - The former CEO, Thomas Kaas Selsø, presented the Board's report on the Company's activities over the past year, addressing shareholder questions regarding the Market Maker agreement with Danske Bank and the potential delisting from Nasdaq Copenhagen [3][4] - Shareholders expressed concerns about the declining share price, attributing it to large shareholders selling their shares, while also acknowledging the Company's successful financing in 2024 and positive research results [4][5] Group 2: Financial Proposals - The audited 2023 annual report was presented, and the discharge of the Board and Executive Management was proposed, with no objections raised from shareholders [8][11] - The expected revenue for the current financial year was projected at DKK 11 million, based on valuations prepared by Baker Tilly and reviewed by Danske Bank [9] - Outstanding convertible loans were confirmed to total approximately DKK 13 million [10] Group 3: Remuneration and Board Elections - The remuneration for the Board of Directors for the 2025 financial year was proposed, with the Chairman receiving DKK 350,000 and Board members receiving DKK 150,000 [14] - All current Board members were re-elected, and two new members, Troels Peter Troelsen and Charlotte Pahl, were elected [16][17] - BDO Statsautoriseret Revisionsaktieselskab was re-elected as the Company's auditor [18] Group 4: Proposals and Authorizations - Three proposals from the Board were discussed, requiring different majorities for adoption, and all were approved without objections [19][20] - The chairman was authorized to file the adopted resolutions with the Danish Business Authority [21] Group 5: Company Overview - Pharma Equity Group A/S is dedicated to advancing the medical projects of its subsidiary, Reponex Pharmaceuticals A/S, with a focus on healthcare and innovative medical solutions [23][24]

Stockholm, 5th of May 2025 - Today Virtune announces that it has finalized its monthly rebalancing for Virtune Crypto Top 10 Index ETP, listed on Nasdaq Stockholm for both the SEK-denominated (ISIN code SE0020052207, ticker name VIR10SEK) and the EUR-denominated (ISIN code SE0020052215, ticker name VIR10EUR) ETP. In addition to the Virtune Crypto Top 10 Index ETP, Virtune's product portfolio includes: Virtune Bitcoin ETPVirtune Stellar ETPVirtune Staked Ethereum ETPVirtune Staked SolanaVirtune Staked Polkad ...

Fire safety: Chubb France deploys AMA's assisted realityfor remote troubleshooting Cergy, Rennes, May 5, 2025 - To speed up the resolution of technical faults, Chubb France, a major player in the fire safety sector, is integrating AMA’s assisted reality into its operations. The aim is to increase efficiency and reduce the number of journeys required to guarantee fast, safe assistance. XpertEye software for remote troubleshooting The partnership has resulted to complement Chubb's tools in the introduction o ...

Core Viewpoint - Jyske Bank has initiated a share repurchase program with a total value of up to DKK 2.25 billion, running from February 26, 2025, to January 30, 2026, in compliance with EU regulations [1]. Group 1 - The share repurchase program is structured in accordance with the EU Commission Regulation No. 596/2014 and the Commission Delegated Regulation (EU) 2016/1052, collectively referred to as the "Safe Harbour Rules" [1]. - As of the latest announcement, Jyske Bank has accumulated a total of 862,155 shares under the program, with an average purchase price of DKK 528.57, totaling DKK 455,705,343 [2]. - Following the recent transactions, Jyske Bank will own a total of 3,627,273 treasury shares, representing 5.64% of the share capital [2]. Group 2 - The transactions under the share repurchase program include specific dates and values, with the most recent purchases occurring from April 28 to May 2, 2025, at varying average prices [2]. - The accumulated shares prior to the latest transactions were 802,274, purchased at an average price of DKK 527.78, amounting to DKK 423,421,598 [2]. - The program aims to enhance shareholder value and is part of Jyske Bank's broader financial strategy [1][2].

Company announcement no. 23 2025Danske BankBernstorffsgade 40DK-1577 København VTel. + 45 33 44 00 0005 May 2025Page 1 of 1Danske Bank share buy-back programme: transactions in week 18On 7 February 2025, Danske Bank A/S announced a share buy-back programme for a total of DKK 5 billion, with a maximum of 45,000,000 shares, in the period from 10 February 2025 to 30 January 2026, at the latest, as described in company announcement no. 6 2025. The Programme is carried out in accordance with Article 5 of Regu ...